Clinical Trials Directory

Trials / Conditions / Microsatellite Stable Colorectal Carcinoma

Microsatellite Stable Colorectal Carcinoma

8 registered clinical trials studyying Microsatellite Stable Colorectal Carcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingSequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Triflu
NCT06522919
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSPhase 2
RecruitingCadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unrese
NCT06218810
Fudan UniversityPhase 2
RecruitingVitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cance
NCT05771181
Fudan UniversityPhase 2
Not Yet RecruitingA Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis
NCT05359393
Fudan UniversityPhase 2
RecruitingA Study of NX-1607 in Adults With Advanced Malignancies
NCT05107674
Nurix Therapeutics, Inc.Phase 1
RecruitingPD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC
NCT06206096
Chinese PLA General HospitalPhase 2
Active Not RecruitingCOM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
NCT04354246
Compugen LtdPhase 1
CompletedStudy of Azacitidine and Durvalumab in Advanced Solid Tumors
NCT02811497
University Health Network, TorontoPhase 2